Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VANTAGE trial of volixibat for cholestatic pruritus in primary biliary cholangitis
jRCT2041240104Active, not recruiting
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Feb 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of volixibat in primary biliary cholangitis (PBC) (3 arms), sponsored by Mirum Pharmaceuticals, Inc. Primary endpoint: Mean change in daily itch score. Started Feb 2025; status: active, not recruiting.
02
Drugs
volixibat
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on jRCT2041240104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041240104.